ArticleGeroScience2026
External validation of a US claims-based frailty indicator and development of a population-specific model for the German healthcare system.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frailty increases the risk of adverse outcomes in older adults and is an important target for preventive care. Clinical frailty measures are established but rarely available at scale due to limited functional data in routine healthcare records. Claims-based frailty prediction models offer a pragmatic approach for population-level risk stratification but are often developed in specific healthcare systems and lack external validation. We aimed to externally validate and recalibrate the Claims-Based-Frailty-Indicator (CFI) and develop a claims-based frailty model for the German healthcare context. We used data from the Berlin Initiative Study, a cohort of older adults with assessment of the frailty phenotype, linked to individual health insurance claims and cause-of-death data. External validation of CFI was assessed by discrimination and calibration. Additionally, a new claims-based frailty model was developed. Model performance and application were evaluated through associations with mortality and hospital admission. Reporting followed TRIPOD statement. Among 1,151 participants (mean age 84.4 years; 55% women), the CFI demonstrated good discrimination (AUC 0.78) but poor calibration; recalibration of intercept improved calibration. Maximizing the Youden Index identified an optimal frailty threshold corresponding to a predicted probability of 0.39. The new model showed improved discrimination (AUC 0.82). Predicted frailty was similarly associated with mortality and hospital admissions as the frailty phenotype. Claims-based frailty models can be validated, recalibrated, and adapted to the German healthcare system. They provide a feasible approach for population-level frailty assessment and may support health services research, risk stratification, and care planning for older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.